Aclaris Therapeutics Inc. (ACRS)
1.59
-0.03 (-1.85%)
At close: Mar 28, 2025, 3:09 PM
Aclaris Therapeutics Ratios Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| PE Ratio | -1.45 | -0.83 | -11.58 | -7.22 | -5.38 | -0.55 | -1.83 | -10.11 | -12.09 | -8 | -13.76 | -22.39 |
| PEG Ratio | -0.04 | 0.13 | 0.36 | -0.11 | 0.08 | 0.04 | -0.03 | -1.2 | 0.36 | -0.02 | -0.22 | n/a |
| PS Ratio | 10.24 | 2.35 | 34.52 | 122.00 | 42.46 | 18.48 | 24.10 | 411.77 | n/a | n/a | n/a | n/a |
| PB Ratio | 1.23 | 0.47 | 5.20 | 4.18 | 7.31 | 1.12 | 1.13 | 3.08 | 3.43 | 1.78 | -5.65 | -12.79 |
| P/FCF Ratio | -9.49 | -0.92 | -15.07 | -15.73 | -7.04 | -0.8 | -2.38 | -12.4 | -16.69 | -7.88 | -14.55 | -23.82 |
| P/OCF Ratio | -9.55 | -0.94 | -15.2 | -15.82 | -7.12 | -0.81 | -2.41 | -12.68 | -16.8 | -8.08 | -15.35 | -23.82 |
| OCF/S Ratio | -1.07 | -2.51 | -2.27 | -7.71 | -5.96 | -22.82 | -9.99 | -32.48 | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | n/a | 0.00 | 0.00 | 0.00 | 0.30 | 0.01 | 0.14 | 0.00 | n/a | n/a | n/a | n/a |
| Quick Ratio | 3.99 | 4.16 | 11.11 | 10.43 | 3.87 | 3.51 | 6.54 | 16.86 | 27.98 | 59.19 | 11.26 | 36.47 |
| Current Ratio | 3.99 | 4.16 | 10.55 | 8.94 | 3.87 | 3.74 | 6.56 | 16.37 | 27.98 | 59.19 | 11.26 | 36.47 |
| Asset Turnover | 0.08 | 0.16 | 0.12 | 0.03 | 0.09 | 0.04 | 0.04 | 0.01 | n/a | n/a | n/a | n/a |
| Interest Coverage | n/a | n/a | -18.12 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.85 | -0.56 | -0.45 | -0.58 | -1.36 | -2.04 | -0.62 | -0.3 | -0.28 | -0.22 | 0.41 | 0.57 |
| Return on Assets (ROA) | -0.6 | -0.45 | -0.35 | -0.45 | -0.72 | -1.45 | -0.48 | -0.28 | -0.27 | -0.22 | -0.49 | -0.37 |
| Return on Capital (ROIC) | -0.75 | -0.58 | -0.37 | -0.29 | -0.91 | -1.46 | -0.55 | -0.31 | -0.29 | -0.22 | -0.54 | -0.38 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 85.09% | 42.14% | 59.80% | 30.29% | 20.81% | 4.07% | 32.12% | 28.28% | n/a | n/a | n/a | n/a |
| Net Profit Margin | -705.48% | -283.15% | -298% | -1.69K% | -789.17% | -3.38K% | -1.32K% | -4.07K% | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -705.48% | -284.32% | -292.11% | -1.34K% | -791.98% | -2.69K% | -1.32K% | -4.18K% | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -758.18% | -311.55% | -286.21% | -967.08% | -785.44% | -2.63K% | -1.34K% | -4.3K% | n/a | n/a | n/a | n/a |
| FCF Margin | -107.88% | -254.84% | -229.13% | -775.65% | -602.99% | -2.32K% | -1.01K% | -3.32K% | n/a | n/a | n/a | n/a |
| EBITDA Margin | -276.28% | -376.22% | -283.53% | -962.28% | -743.52% | -2.15K% | -800.53% | -3.18K% | n/a | n/a | n/a | n/a |